基本信息
文件名称:Elobixibat-d5-A-3309-d-sub-5-sub-生命科学试剂-MCE.pdf
文件大小:474.9 KB
总页数:1 页
更新时间:2025-05-21
总字数:约3.39千字
文档摘要

Hotline:400-820-3792

Inhibitors?ScreeningLibraries?Proteins

www.MedChemE

Elobixibat-d5

Cat.No.:HY-15790S

Synonyms:A3309-d;AZD7806-d

55

分?式:C??H??D?N?O?S?

分?量:700.92

作?靶点:Isotope-LabeledCompounds;InterleukinRelated;Apical

Sodium-DependentBileAcidTransporter;TNFReceptor

作?通路:Others;Immunology/Inflammation;MembraneTransporter/Ion

Channel;Apoptosis

储存?式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

?物活性Elobixibat-d5(A3309-d5)是氘代标记的Elobixibat.Elobixibat(A3309;AZD7806)是?种?服有效的Apical

Sodium-DependentBile(IBAT)抑制剂,IC50值分别为0.53nM(?类IBAT),0.13nM(??IBAT),5.8nM(

?类IBAT)。Elobixibat可降低LDL胆固醇,增加?清GLP-1,促进结肠运动,并具有治疗代谢综合征的潜?

。Elobixibat可?于便秘、?脂异常、?酒精性肝炎和肝脏肿瘤的研究[1][2][3]。

体外研究Stableheavyisotopesofhydrogen,carbon,andotherelementshavebeenincorporatedintodrugmolecules,

largelyastracersforquantitationduringthedrugdev